Personalizing Cancer Therapy with FDG PET: From RECIST to PERCIST

• You have access

  Assessing Tumor Response to Therapy

  Wolfgang A. Weber

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 1S-10S; DOI: https://doi.org/10.2967/jnumed.108.057174
• You have access

  Standards for PET Image Acquisition and Quantitative Data Analysis

  Ronald Boellaard

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 11S-20S; DOI: https://doi.org/10.2967/jnumed.108.057182
• You have access

  PET/CT for Therapy Response Assessment in Lymphoma

  Martin Hutchings and Sally F. Barrington

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 21S-30S; DOI: https://doi.org/10.2967/jnumed.108.057190
• You have access

  Role of ¹⁸F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer

  Rodney J. Hicks

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 31S-42S; DOI: https://doi.org/10.2967/jnumed.108.057216
• You have access

  Monitoring and Predicting Response to Therapy with ¹⁸F-FDG PET in Colorectal Cancer: A Systematic Review

  Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224
• You have access

  Response to Therapy in Breast Cancer

  Norbert Avril, Stefanie Sassen and Rebecca Roylance

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 55S-63S; DOI: https://doi.org/10.2967/jnumed.108.057240
• You have access

  The Role of ¹⁸F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries

  Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257
• You have access

  PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma

  Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208
• You have access

  ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer

  Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232
• You have access

  Monitoring Predominantly Cytostatic Treatment Response with ¹⁸F-FDG PET

  Kaiyumars B. Contractor and Eric O. Aboagye

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 97S-105S; DOI: https://doi.org/10.2967/jnumed.108.057273
• You have access

  Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET

  Mark P.S. Dunphy and Jason S. Lewis

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 106S-121S; DOI: https://doi.org/10.2967/jnumed.108.057281
• You have access

  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

  Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge

  Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307